SCHEMBL6719067

SCHEMBL6719067

CSn1cccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7821507 0.77 FBP1 (0.37)
SCHEMBL3203791 0.72
SCHEMBL25569 0.72
SCHEMBL24253772 0.72
SCHEMBL19977107 0.69
SCHEMBL7711325 0.67
SCHEMBL3926189 0.67 FBP1 (0.31)
SCHEMBL2375082 0.64
SCHEMBL6126771 0.64
SCHEMBL8025968 0.64 SMPD3 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118345467-A Cyanide-free gold plating solution and gold plating method 光华科学技术研究院(广东)有限公司 2024-07-16 CN claimed
CN-110483487-B 2-thiomethylpyrazole pyrimidone compound, preparation method thereof, pharmaceutical composition and application 云南大学 2022-07-12 CN claimed
US-5714491-A ANTICANCER AND ANTITUMOR AGENT CELLTECH THERAPEUTICS LIMITED (GB) 1998-02-03 US claimed
US-20240239835-A9 NEUROACTIVE STEROIDS AND THEIR METHODS OF USE SAGE THERAPEUTICS, INC. 2024-07-18 US disclosed
CN-118345467-A Cyanide-free gold plating solution and gold plating method 光华科学技术研究院(广东)有限公司 2024-07-16 CN disclosed
US-20240208968-A1 ALPHA V BETA 6 AND ALPHA V BETA 1 INTEGRIN INHIBITORS AND USES THEREOF DICE MOLECULES SV, INC. 2024-06-27 US disclosed
EP-3753937-B1 ATR INHIBITOR AND APPLICATION THEREOF WUXI BIOCITY BIOPHARMACEUTICS CO LTD (CN) 2024-01-10 EP disclosed
EP-3986890-B1 BENZISOXAZOLE SULFONAMIDE DERIVATIVES PFIZER (US) 2023-11-15 EP disclosed
US-11780859-B2 Halogen free syntheses of aminosilanes by catalytic dehydrogenative coupling L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude (FR) 2023-10-10 US disclosed
WO-2023138621-A1 ATR INHIBITORS AND USES THEREOF SHANGHAI ANTENGENE CORPORATION LIMITED (CN) 2023-07-27 WO disclosed
US-20230219986-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-07-13 US disclosed
EP-0605682-A1 PEPTIDYL DERIVATIVES AND THEIR USE AS METALLOPROTEINASES INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1994-07-13 EP disclosed
WO-1994013643-A1 PYRAZOLES AND PYRAZOLOPYRIMIDINES HAVING CRF ANTAGONIST ACTIVITY PFIZER INC. (US) 1994-06-23 WO disclosed
US-5300501-A Metalloproteinase inhibitors CELLTECH LIMITED (GB) 1994-04-05 US disclosed
WO-1993024475-A1 SULPHAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS CELLTECH LIMITED (GB) 1993-12-09 WO disclosed
WO-1993024449-A1 PEPTIDYL DERIVATIVES AND THEIR USE AS METALLOPROTEINASES INHIBITORS CELLTECH LIMITED (GB) 1993-12-09 WO disclosed
EP-0542872-A1 HERBICIDAL SUBSTITUTED ARYL ALKYLSULFONYL PYRAZOLES MONSANTO COMPANY (US) 1993-05-26 EP disclosed
WO-1992009565-A1 PEPTIDYL DERIVATIVES CELLTECH LIMITED (GB) 1992-06-11 WO disclosed
EP-0489577-A1 Peptidyl derivatives CELLTECH LIMITED (GB) 1992-06-10 EP disclosed
EP-0489579-A1 Peptidyl derivatives CELLTECH THERAPEUTICS LIMITED (GB) 1992-06-10 EP disclosed